Fifth Third Bancorp lifted its stake in shares of Xylem Inc. (NYSE:XYL – Free Report) by 97.4% during the first quarter, HoldingsChannel.com reports. The firm owned 78,502 shares of the industrial products company’s stock after purchasing an additional 38,741 shares during the period. Fifth Third Bancorp’s holdings in Xylem were worth $9,381,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. J. Stern & Co. LLP boosted its holdings in Xylem by 12,326.6% during the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after buying an additional 45,082,435 shares in the last quarter. Norges Bank purchased a new position in shares of Xylem in the fourth quarter valued at $361,012,000. Balyasny Asset Management L.P. raised its stake in shares of Xylem by 346.2% during the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after buying an additional 553,152 shares during the last quarter. Adage Capital Partners GP L.L.C. purchased a new stake in shares of Xylem in the second quarter valued at about $64,407,000. Finally, SG Americas Securities LLC lifted its stake in Xylem by 255.4% in the 1st quarter. SG Americas Securities LLC now owns 681,904 shares of the industrial products company’s stock valued at $81,488,000 after buying an additional 490,040 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Trading Down 0.2%
NYSE XYL opened at $121.33 on Thursday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The company has a 50-day simple moving average of $112.86 and a 200-day simple moving average of $123.58. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The firm has a market capitalization of $28.84 billion, a PE ratio of 30.18, a price-to-earnings-growth ratio of 1.73 and a beta of 1.03.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were given a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.4%. Xylem’s dividend payout ratio is 42.79%.
Insider Buying and Selling
In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on XYL shares. JPMorgan Chase & Co. reduced their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Barclays lowered their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. UBS Group increased their price objective on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Stifel Nicolaus dropped their target price on Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Finally, Citigroup cut their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $153.54.
Get Our Latest Research Report on XYL
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Recommended Stories
- Five stocks we like better than Xylem
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
